Navigation Links
Cephalon Reported Financial Results for the Second Quarter of 2011
Date:8/2/2011

14372,641OTHER INCOME (EXPENSE):Interest income

1,2531,3002,2703,230Interest expense

(24,475)(28,182)(48,682)(54,973)Change in fair value of investments

99,473-264,208-Other income (expense), net

(26,360)(9,332)(29,388)(16,603)49,891(36,214)188,408(68,346)INCOME BEFORE INCOME TAXES

198,281155,647512,622304,295INCOME TAX EXPENSE

83,08963,254185,820111,565NET INCOME

115,19292,393326,802192,730NET LOSS (INCOME) ATTRIBUTABLE TO NONCONTROLLING INTEREST

2,983(3,329)2,4616,899NET INCOME ATTRIBUTABLE TO CEPHALON, INC.

$ 118,175$   89,064$
329,263$
99,629BASIC INCOME PER COMMON SHARE ATTRIBUTABLE TO CEPHALON, INC.

$
.54$
.18$
4.32$
2.66DILUTED INCOME PER COMMON SHARE ATTRIBUTABLE TO CEPHALON, INC.

$
.34$
.11$
3.97$
2.46WEIGHTED AVERAGE NUMBER OF COMMONSHARES OUTSTANDING ATTRIBUTABLE TO CEPHALON, INC.

76,67975,19276,21375,092WEIGHTED AVERAGE NUMBER OF COMMONSHARES OUTSTANDING-ASSUMING DILUTIONATTRIBUTABLE TO CEPHALON, INC.

88,30380,50782,87181,223CEPHALON, INC. AND SUBSIDIARIESReconciliation of GAAP Net Income to Adjusted Net Income Attributable to Cephalon, Inc.(Unaudited)Three Months EndedJune 30,20112010GAAP NET INCOME ATTRIBUTABLE TO CEPHALON, INC.

$ 118,175$   89,064Cost of sales adjustments

(834)

(1)

52,209

(1)Research and development adjustments

320

(2)

317

(2)Selling, general and administrative adjustments

24,774

(3)

9,225

(3)Change in fair value of contingent consideration adjustment

2,600

(4)Restructuring adjustment

4,279

(5)

4,581

(5)Impairment and (gain) loss on sale of assets adjustment

48,408

(6)Interest expense adjustment

16,016

(7)

18,476

(7)Change in fair value of investments adjustment

(99,473)

(8)Other (income) expense adjustment

16,48
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Cephalon Quarterly Conference Call Invitation
2. Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices
3. $425 Million Cephalon Civil Settlement and Criminal Fine; In Americas Largest
4. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
5. Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
6. Cephalon Reports Another Strong Quarter
7. Cephalon, Inc. to Webcast Analyst Day
8. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
9. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
10. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
11. Cephalons New Product Launches Pace Record 2008 Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... METTLER TOLEDO's ... narrows down the product choices to a manageable shortlist of bench and floor ... to models that fit best with the customer’s industry and application. , ...
(Date:8/27/2015)... Irvine, CA (PRWEB) , ... August 27, 2015 ... ... leader in Personalized Medicine, recently presented new data on the relationship of genetics ... 2015 20th World Congress on Heart Disease in Vancouver, British Columbia, Canada. The ...
(Date:8/26/2015)... 26, 2015 /PRNewswire/ - iCo Therapeutics ("iCo" or "the ... results for the quarter ended June 30, 2015. ... dollars and presented under International Financial Reporting Standards ... respect to our Oral Amp B program, rapidly ... said Andrew Rae , President & CEO ...
(Date:8/26/2015)... ... 26, 2015 , ... Lee Biosolutions, a global biotech healthcare ... of highly valued cardiac markers used in early detection of heart disease due ... has led to the development and commercialization of important cardiac biomarkers used in ...
Breaking Biology Technology:METTLER TOLEDO Updates Online Scale Selection Tool 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2
... , , ... , Roche Applied Science pioneered the ... High Fidelity and,Expand Long Template PCR Systems were the first commercially,available ... respectively. The Expand,High FidelityPLUS PCR System is a next-generation blend,consisting of ...
... , , , , , ... PCR-Grade Nucleotides. These larger pack sizes,combine the best available quality with attractive pricing. , ... Single dNTPs , , ... in 500-mol pack sizes.,The Deoxynucleoside Triphosphate Set, containing all four dNTPs (dATP, dCTP, dGTP, and dTTP) ...
... , , , , ... , A New Tool for the Rapid and Efficient ... , , , Swabs are ... agents (bacteria, fungi, or viruses). After the,swab procedure, the infectious agents are typically,released into a ...
Cached Biology Technology:Combine High Yield, Great Accuracy and the,Prevention of Carry-over Contamination by Using,the Novel Expand High FidelityPLUS PCR System 2PCR-Grade Nucleotides,Larger Pack Sizes Now Available 2S.E.T.S. Swab Extraction Tube System 2
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015  Sarcos ... today it will unveil its "Guardian S" snake robot, ... National Tactical Officers Association Conference on August 30 in ... is the first-ever commercially available energetically autonomous snake robot, ... in-field trials and is protected by more than 50 ...
(Date:8/20/2015)... Aug. 20, 2015 The wearable technology ... are active and healthy. However, wearable technology has ... environment to help improve diagnostic capabilities and therapeutic ... the Wearable Technologies Conference 2015 , where ... for wearables in healthcare.    "Over ...
(Date:8/19/2015)...  VOXX International Corporation (Nasdaq: VOXX ) ... Definitive Agreement to purchase the assets, inclusive of ... EyeLock through an acquiring entity.  Upon consummation of ... in the acquiring entity. The closing of the ...  Expanding on its existing supply chain and distribution ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
... Soybean production has continued to increase in the Northeast ... the crop and many experienced growers planting alongside corn crops. ... with a corn planter in 30-inch rows instead of 7.5-inch ... a Cornell University scientist, investigated the response of two soybean ...
... L. Boren announced today that OU is establishing an ... expertise to benefit Oklahoma and the nation, including emerging ... led by a national expert, who will be appointed ... million gift from Corix, a multi-utility infrastructure company, which ...
... grant totaling $2.2 million shows how the University of ... using technology to advance the cutting-edge field of personalized ... their genetic make-up. The grant also highlights the ... Institute (CCTSI) to bring scientific discoveries to the bedside ...
Cached Biology News:OU establishes a new water and sustainability institute 2OU establishes a new water and sustainability institute 3Personalizing medicine 2Personalizing medicine 3
...
...
... designed to rapidly and reliably amplify unknown ... Technology. APAgene provides hassle-free, ready-to use components, ... ingredients are provided in each kit. The ... for insert-end amplification of large clones such ...
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: